BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Clinical trial NCT07678229 · RECRUITING

Trial details

NCT number: NCT07678229
Sponsor: Rong Tao
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma

Start date: 2026-08-11
Primary completion: 2031-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.